IMCD Malaysia acquires Euro Chemo-Pharma to accelerate growth in life science markets
19 Maggio 2023 - 7:00AM
IMCD Malaysia acquires Euro Chemo-Pharma to accelerate growth in
life science markets
ROTTERDAM, The Netherlands (19 May 2023) – IMCD N.V.
("IMCD" or "Company"), a leading distributor, formulator, and
solutions provider of speciality chemicals and ingredients, today
announces that IMCD has signed an agreement to acquire 100% of the
shares of the speciality distribution company, Euro Chemo-Pharma
Sdn Bhd ("Euro Chemo-Pharma") and its wholly owned subsidiary,
Biofresh Green Sdn Bhd ("Biofresh").
Euro Chemo-Pharma was founded in Malaysia in 1975, offering a
wide range of products, mainly food, pharmaceutical and personal
care applications. Headquartered in Penang, with offices and
warehouses also in Kuala Lumpur and Johor, it ensures the full
coverage of the Malaysian market. The company also represents
leading global suppliers providing its customers with an extensive
portfolio backed by in-depth formulation expertise. With a
generated revenue of approximately MYR 270 million (ca. EUR 55
million) in the financial year that ended on June 30, 2022, Euro
Chemo-Pharma adds approximately 124 employees to the IMCD Malaysia
team and an application laboratory in Penang.
Additionally, Euro Chemo-Pharma’s subsidiary, Biofresh, includes
blending, mixing, and compounding of food and flavour ingredients
and holds the Halal certification.
"Euro Chemo-Pharma's strategic positioning is fully aligned with
IMCD, providing us the complementary portfolio to accelerate growth
in the Malaysian market," remarked Andreas Igerl, President at IMCD
APAC. "In addition, we aim to leverage the suppliers’ synergies we
gain from them to develop further our life science business in the
Asia Pacific markets," concluded Igerl.
"We have managed to grow the company to be the largest and most
efficient speciality ingredients distributor in Malaysia,"
commented Jeryl Tan, Executive Director at Euro Chemo-Pharma. "With
the mindset that if you don’t step forward, you are always in the
same place, we believe that IMCD would be our best partner in the
journey to drive growth and provide an exciting new home for our
people," concluded Tan.
The closing of the transaction is subject to customary closing
conditions and is expected to take place in the last quarter of
2023.
Attached, the press release in pdf format, the main visual, and
the photo caption.
- Photo - IMCD Malaysia acquires Euro Chemo-Pharma to accelerate
growth in life science markets
- Press Release - IMCD Malaysia acquires Euro Chemo-Pharma to
accelerate growth in life science markets
- Photo Caption_IMCD Malaysia acquires Euro Chemo-Pharma to
accelerate growth in life science markets
Grafico Azioni IMCD NV (EU:IMCD)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni IMCD NV (EU:IMCD)
Storico
Da Mag 2023 a Mag 2024